Unlock instant, AI-driven research and patent intelligence for your innovation.

Extracellular ABL1 kinase activity detection reagent kit and application thereof

A detection kit and kinase activity technology, applied in the field of enzyme activity detection, can solve the problems of long cycle, difficult expression, difficult CML treatment, etc., and achieve the effect of simple operation

Pending Publication Date: 2020-06-23
广州安镝声生物医药科技有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The complete ABL1 protein is large and difficult to express
[0004] Some mutations in the ABL1 protein in patients make it difficult to treat CML
At present, some inhibitors based on ABL1 protein have been developed, including imatinib, nilotinib, bosutinib, etc., all of which have a good inhibitory effect on ABL1 protein, but Due to mutations in some positions of the protein, some patients develop tolerance
On the other hand, in vivo research often takes a long time, and the complexity of the biological environment in vivo also sets huge obstacles for the development of ABL1 inhibitors

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Extracellular ABL1 kinase activity detection reagent kit and application thereof
  • Extracellular ABL1 kinase activity detection reagent kit and application thereof
  • Extracellular ABL1 kinase activity detection reagent kit and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] An embodiment of the extracellular ABL1 kinase activity detection kit of the present invention comprises the following components:

[0031] (1) ATP;

[0032] (2) ABL1 substrate polypeptide, the amino acid sequence of which is: EAIYAAPFAKKK (SEQ ID NO.1);

[0033] (3) ABL1 protein fragment sequence 1, its amino acid sequence is as follows:

[0034] EYLLSSGINGSFLVERSESSPGQRSISLRYEGRVYHYRINTASDGKLVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVDDFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERRPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGVRGAVSTLLQAPELPTKTRSRRAAEHRDTTDVPEMPHSK(SEQ ID NO.2);

[0035] (4) ABL1 protein fragment sequence 2, its amino acid sequence is as follows:

[0036] MGSSHHHHHHSSGLVPRGSHMGPSENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLS...

Embodiment 2 Embodiment 1

[0038] Preparation of ABL1 protein fragment sequences 1 and 2 in Example 2 Example 1

[0039] 1) Plasmid transformation and shake flask culture

[0040] 1: Add 1 μg of pET-28a(+) and Kan plasmid expressing PTK domain to 100 μl Arctic Expression (DE3) competent bacteria, and place on ice for 20 minutes;

[0041] 2: Heat shock at 42°C for 90 sec, quickly place on ice for 3 min; add 600 μl LB culture solution;

[0042] 3: Shake at 220 rpm for 1 hour at 37°C, take 200 μl of the bacterial solution and spread it on an LB plate containing 50 μg / ml Kan, and incubate overnight at 37°C;

[0043] 4: The next morning, pick the monoclonal on the plate and inoculate it into a test tube containing 50 μg / ml Kan in 4ml LB medium, culture at 37°C with shaking at 220rpm until about 1:00 p.m., and the OD is about 0.6;

[0044] 5: According to the ratio of 1:250, inoculate in 1L LB culture medium of 100μg / ml Kan, shake at 220rpm at 37°C until the cell OD 600 0.5-0.6 (about 3h);

[0045] 6: Add...

Embodiment 3

[0062] Example 3 Using the kit of Example 1 to detect the effect of berberine inhibiting ABL1 kinase

[0063] The detection method that berberine inhibits ABL1 kinase activity comprises the following reaction steps:

[0064] 1. Add 1 μL berberine to each well of the drug treatment group successively, the concentration of berberine is (0.2, 4, 8, 10 μmol / L), 1uL ABL1 kinase substrate polypeptide (30ng EAIYAAPFAKKK) and 5uL ATP (2 μmol / L) , 1uL ABL protein fragment (30ng, the corresponding polypeptide of SEQ ID NO.2 or SEQ ID NO.3);

[0065] 2. Three replicate wells were set up for each group. After incubation at 30°C for 20 min, 10 μL of the luciferase-substrate mixture was added to each well, and the chemiluminescence value was measured on a microplate reader.

[0066] According to the detected luminescence value, the corresponding standard curve was drawn, and the standard curve was as follows: Figure 4 Shown; The drug inhibitory activity result that adopts ABL1 protein f...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an extracellular ABL1 kinase activity detection reagent kit. The extracellular ABL1 kinase activity detection reagent kit comprises the following reagents of ATP, ABL1 substrate polypeptide, a reaction buffer solution, and ABL1 proteins or polypeptide fragments corresponding to an ABL1 kinase structured domain (PTK). The ABL1 kinase activity detection reagent kit disclosedby the invention is simple, convenient and effective to operate, extracellular high-flux detection of the activity of ABL1 kinase can be performed, and the extracellular ABL1 kinase activity detectionreagent kit can be applied to large-scale screening of inhibitors of the activity of the ABL1 kinase.

Description

technical field [0001] The invention relates to the technical field of enzyme activity detection, in particular to an extracellular ABL1 kinase activity detection kit. Background technique [0002] Non-receptor tyrosine kinase ABL1 widely exists in various mammalian tissue cells, and participates in cell proliferation, cell cycle, apoptosis, DNA damage repair, and inflammatory response by mediating tyrosine phosphorylation modification of substrate proteins , the regulation of life processes such as tumorigenesis and formation. Under normal physiological conditions, the kinase activity of ABL1 is strictly regulated, and the kinase activity of ABL1 activated by various cytokines, oxidative stress or DNA damage stress is greatly increased, and it exerts different physiological functions by localizing in different cell substructures . In the process of cell signal transduction and transformation, the BCR-ABL fusion protein promotes the unlimited proliferation and migration of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/48
CPCC12Q1/485G01N2333/9121
Inventor 费嘉阴钊
Owner 广州安镝声生物医药科技有限公司